Skip to content
Top Globe News – Lifestyle
Author:
BOSTON SCIENTIFIC CORPORATION
FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints
May 19, 2026
Boston Scientific enters into $2 billion accelerated share repurchase agreement
May 18, 2026
Boston Scientific announces strategic investment in MiRus LLC
May 18, 2026
Boston Scientific announces participation in Bernstein’s 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results
May 4, 2026
Data at Heart Rhythm 2026 highlight key Boston Scientific therapies
April 29, 2026
Boston Scientific announces results for first quarter 2026
April 29, 2026
Boston Scientific announces conference call discussing first quarter 2026 results
March 30, 2026
CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
March 28, 2026
HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
March 28, 2026